IDO1 and colonic neoplasm: Liu's experiments confirmed that in non‐immune environments, elevated levels of IDO1 and its metabolite Kyn in colon cancer cells significantly promote CDC20 transcription, and inhibiting IDO induces mitotic death through CDC20 [62].